European Journal of Hospital Pharmacy

Papers
(The TQCC of European Journal of Hospital Pharmacy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Antifungal drug resistance: an update45
CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists’ interventions37
Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 235
Performance and risks of ChatGPT used in drug information: an exploratory real-world analysis30
Toward a better understanding about real-world evidence19
Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital13
Therapeutic efficacy of tacrolimus in vernal keratoconjunctivitis: a meta-analysis of randomised controlled trials12
A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report12
Switching of monoclonal antibodies against calcitonin gene-related peptide in chronic migraine in clinical practice: a case series12
Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic11
Automated unit dose dispensing systems producing individually packaged and labelled drugs for inpatients: a systematic review11
Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards10
Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model: the IRAFE study10
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients10
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain10
Evaluation of inappropriate antibiotic prescribing and management through pharmacist-led antimicrobial stewardship programmes: a meta-analysis of evidence9
Managing antibiotic shortages: lessons from EAHP and ECDC surveys9
COVID-19 vaccine triggered autoimmune hepatitis: case report9
Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance9
Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results9
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-199
Widening the net: a literature review of antimicrobial agents with potential suitability for outpatient parenteral antimicrobial therapy services—the importance of storage and stability9
What influences the implementation and sustainability of antibiotic stewardship programmes in hospitals? A qualitative study of antibiotic pharmacists’ perspectives across South West England8
Managing the risk of shortages and medication errors with curares during the COVID-19 pandemic: a hospital pharmacy experience8
Identification and safe storage of look-alike, sound-alike medicines in automated dispensing cabinets8
Patient prioritisation for hospital pharmacy services: current approaches in the UK7
Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies ± other therapies in lung cancer: a systematic review and meta-analysis7
An unusual case of piperacillin-tazobactam-induced fever, eosinophilia, thrombocytopenia and liver damage7
Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis7
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series7
Outcomes ofClostridioides difficileinfection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study6
Therapeutic drug monitoring of amikacin: quantification in plasma by liquid chromatography-tandem mass spectrometry and work experience of clinical pharmacists6
The importance of publishing research protocols for pharmacoeconomic studies6
RETRACTED: Specific features of rational pharmacotherapy in elderly patients6
Use of simulation for education in hospital pharmaceutical technologies: a systematic review6
Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report6
Pharmacy preparations and compounding6
Factors influencing the implementation of clinical pharmacy services on paediatric patient care in hospital settings5
Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin5
Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: the Granada Statements5
Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-195
Red for danger in systematic reviews?5
Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results5
Medication-related problems in critical care survivors: a systematic review5
Surgical pharmacy: the knowledge system of surgical pharmacists4
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients4
Availability of antidotes in Moroccan hospitals: a national survey4
Prescription profile in patients with SARS-CoV-2 infection hospitalised in Aragon, Spain4
Impact of pharmacist-led interventions in improving adherence to glaucoma medications in the geriatric population4
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document4
Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance4
Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome4
Comparison of metaraminol versus no metaraminol on time to resolution of shock in critically ill patients4
Lessons learnt from the COVID-19 pandemic: results of EAHP survey on the future crisis preparedness of hospital pharmacies4
Physicochemical stability of cefiderocol, a novel siderophore cephalosporin, in syringes at 62.5 mg/mL for continuous administration in intensive care units4
Rhabdomyolysis in a male adolescent associated with monotherapy of fluvoxamine4
Polymyxin B-related neurotoxicity: a brief case report3
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients3
Influence of baseline characteristics and stratification level of patients living with HIV on pharmaceutical interventions developed according to the Capacity-Motivation-Opportunity methodology3
Criteria for the selection of paediatric patients susceptible to reconciliation error3
Benefit versus toxicity risk of digoxin in patients with COVID-193
Global research trends and hotspots in pharmaceutical care: a bibliometric analysis and visualisation using CiteSpace and VOSviewer3
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study3
Clinical pharmacists’ services, role and acceptance: a national Swedish survey3
Epileptic convulsions probably induced by desloratadine: a case report3
Retrospective review of medication-related incidents at a major teaching hospital and the potential mitigation of these incidents with electronic prescribing and medicines administration3
Improving shared decision-making in pharmacist-led haematology clinics: a ‘Plan Do Study Act’ approach3
Off-label use in adult palliative care – more common than expected. A retrospective chart review3
5S management improves the service quality in the outpatient-emergency pharmacy: from management process optimisation to staff capacity enhancement3
Development and validation of a ready-to-use score to prioritise medication reconciliation at patient admission in an orthopaedic and trauma department3
Comparison of area under the curve for vancomycin from one- and two-compartment models using sparse data3
Is sitagliptin effective for the treatment of COVID-19?3
Antimicrobial resistance: a major priority for global focus3
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors3
Tezacaftor-ivacaftor use in routine care of adults with cystic fibrosis: a medicine use evaluation3
Levofloxacin induced bullous fixed drug eruption: a rare case report3
The European COVID-19 drugs calculation tool: an aid for the estimation of the drugs needed during the SARS-CoV 2 pandemic3
A patient with ulcerative colitis treated with a combination of vedolizumab and tofacitinib3
Effect of a pharmacist-led educational intervention on clinical outcomes: a randomised controlled study in patients with hypertension, type 2 diabetes and hypercholesterolaemia3
Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs3
Development of a list with renally relevant drugs as a tool to increase medicines optimisation in patients with chronic kidney disease3
European health data space proposal launched3
EMA/HMA joint statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU3
Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital3
Successful treatment of Verona integron-encoded metallo-β-lactamase-producingKlebsiella pneumoniaeinfection using the combination of ceftazidime/avibactam and aztreonam3
Tobramycin and vestibulotoxicity: retrospective analysis of four cases3
Pharmacokinetic/pharmacodynamic analysis of vancomycin in patients withEnterococcus faeciumbacteraemia: a retrospective cohort study2
Assessment of the effectiveness of tocilizumab on mortality and progression to mechanical ventilation or intensive care in patients with COVID-19 admitted to a tertiary hospital2
Automatic dispensing cabinets and governance of controlled drugs: an exploratory study in an intensive care unit2
Comparison of three automated compounding devices for parenteral nutrition according to four key technical tests2
A qualitative evaluation of weekly reflective practice sessions for the intensive care unit pharmacy team during the COVID-19 pandemic2
Effects of angiotensin II receptor blockers on serum potassium level and hyperkalemia risk: retrospective single-centre analysis2
Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumab2
Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA2
Lopinavir/ritonavir, a new galenic oral formulation from commercial solid form, fine-tuned by nuclear magnetic resonance spectroscopy2
Rosuvastatin-induced rhabdomyolysis: case report and call for proactive multifactorial risk assessment and preventive management of statin therapy in high-risk patients2
Self-administration of medications in inpatient postnatal women: an opportunity to empower self-care, improved medicines knowledge and adherence utilising clinical pharmacists and midwifery workforce 2
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze2
Compliance with status epilepticus management protocol and effect on clinical outcomes in children with status epilepticus2
A pharmacovigilance study on antiepileptic medications in a paediatric hospital in Italy2
Infliximab: a single-centre, prospective, observational evaluation of TDM data in patients with IBD2
Capillary electrophoresis in parenteral nutrition control – validation of two analytical methods: Amino acids/glucose/glucose-1-phosphate and K/Na/Ca/Mg2
Vancomycin in neonatal sepsis: predictive performance of a Chinese neonatal population pharmacokinetic model and clinical efficacy evaluation2
Management of heparin-induced thrombocytopenia during extracorporeal membrane oxygenation support: a case of neutropenia caused by argatroban anticoagulation2
Tocilizumab in COVID-19 management: addressing time of starting treatment2
Drug-related bradycardia precipitating hospital admission in older adults: an ongoing problem2
Potential costs and consequences associated with medication error at hospital discharge: an expert judgement study2
Unexpected overdose of oral cyclosporine in a kidney transplant patient: a case report2
Assessing health literacy in transplant patients to better tailor the content of their therapeutic education: an observational study2
Transition to adult services: the current and potential role of the UK hospital pharmacist2
Risperidone is not only a prodrug: psychosis induced by medication switch from risperidone to paliperidone – a case report2
Hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction: a case report2
Haemolytic anaemia induced by flutamide: a case report2
Hospital pharmacy response to COVID-19 at two UK teaching hospitals: a departmental review of actions implemented to inform future strategy2
Using risk analysis to anticipate and mitigate failures during a hospital pharmacy relocation2
Failure mode and effect analysis applied to improve the medication management process in a pharmacy of a teaching hospital and a proposal for a simplified rating system2
Analysis of production time and capacity for manual and robotic compounding scenarios for parenteral hazardous drugs2
Evaluation of the impact of the addition of a heart failure prescribing pharmacist to consultant-led heart failure ward round at a tertiary hospital2
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence2
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations2
How can we optimise the pharmaceutical analysis of radiopharmaceutical pediatric prescriptions?2
Retrospective study of patient characteristics and treatment for mucormycosis in post COVID-19 population in a tertiary care hospital2
Therapeutic drug monitoring of linezolid: HPLC-based assays for routine quantification of linezolid in human serum and cerebrospinal fluid2
Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use2
Antimicrobial resistance in Nigeria: challenges and charting the way forward2
Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction2
Using Healthcare Failure Mode and Effect Analysis in prospective medication safety risk management in secondary care inpatient wards2
Study of overall survival associated with nintedanib and pirfenidone in patients with idiopathic pulmonary fibrosis: a real-life comparison2
Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor?2
Effectiveness of antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 infection2
Stability and compatibility of admixtures containing bupivacaine hydrochloride and ketorolac tromethamine for parenteral use2
The role of clinical trials in the sustainability of the Italian national health service cancer drug expenditure2
Benefits of using a microencapsulated vitamin D delivery system in women with polycystic ovary syndrome2
Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia2
Analysis of the clinical characteristics of dabigatran-induced oesophagitis2
Factors associated with potential drug–drug interactions in psychiatric inpatients2
Clinical frailty and polypharmacy in older emergency critical care patients: a single-centre retrospective case series2
Use of chronic medications and risk of death due to COVID-19 in hospitalised patients2
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials2
Rare case report of moxifloxacin-induced persistent hiccups2
Pharmacotherapeutic management of Parkinson’s disease inpatients: how about asking hospital pharmacists?2
Impact of transplant pharmacists on length of stay and 30-day hospital readmission rate: a single-centre retrospective cohort study2
Factors affecting voriconazole concentration to dose ratio changes according to route of administration2
Defining innovativeness of high-technology medical devices in an Italian region2
Comparison of pharmacokinetics software for therapeutic drug monitoring of piperacillin in patients with severe infections2
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part C: applying risk assessment and risk control in practice2
Dl-3-n-butylphthalide induced anaphylactic shock: a case report2
Risk of acute kidney injury by initiation of non-steroidal anti-inflammatory drugs in hospitalised patients treated with diuretics and renin–angiotensin–aldosterone system inhibitors2
Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?2
Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature2
Impact of automated dispensing cabinets on dispensing errors, interruptions and pillbox preparation time2
Development and Delphi validation of a Best Possible Medication History form2
0.098411798477173